Go Pro

MarketBeat’s Top 5 Rated Small-Cap Stocks

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Trevi Therapeutics Right Now?

Before you consider Trevi Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trevi Therapeutics wasn't on the list.

While Trevi Therapeutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Ryan Hasson
About The Author

Ryan Hasson

Contributing Author

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Atai Beckley (ATAI)
3.2731 of 5 stars
$5.23-0.8%N/AN/AModerate Buy$16.00
Mind Medicine (MindMed) (MNMD)N/A$0.69flatN/AN/AN/AN/A
LendingTree (TREE)
4.1815 of 5 stars
$44.600.7%N/A3.46Buy$68.60
CorMedix (CRMD)
3.1927 of 5 stars
$8.376.6%N/A3.92Moderate Buy$15.00
Trevi Therapeutics (TRVI)
2.4106 of 5 stars
$18.24-2.2%N/AN/ABuy$22.67
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines